卵巢癌的认识、诊断与治疗的最新进展
Recent Advances in Understanding, Diagnosing, and Treating Ovarian Cancer.
作者信息
Mills Kathryn, Fuh Katherine
机构信息
Washington University School of Medicine, St. Louis, MO, USA.
出版信息
F1000Res. 2017 Jan 27;6:84. doi: 10.12688/f1000research.9977.1. eCollection 2017.
Abstract
Ovarian cancer, a term that encompasses ovarian, fallopian, and peritoneal cancers, is the leading cause of gynecologic cancer mortality. To improve patient outcomes, the field is currently focused on defining the mechanisms of cancer formation and spread, early diagnosis and prevention, and developing novel therapeutic options. This review summarizes recent advances in these areas.
摘要
卵巢癌，这一术语涵盖卵巢癌、输卵管癌和腹膜癌，是妇科癌症死亡的主要原因。为改善患者预后，该领域目前专注于确定癌症形成和扩散的机制、早期诊断和预防，以及开发新的治疗选择。本综述总结了这些领域的最新进展。
相似文献
1
Recent Advances in Understanding, Diagnosing, and Treating Ovarian Cancer.卵巢癌的认识、诊断与治疗的最新进展
F1000Res. 2017 Jan 27;6:84. doi: 10.12688/f1000research.9977.1. eCollection 2017.
2
Peritoneal carcinoma in women with genetic susceptibility: implications for Jewish populations.具有遗传易感性的女性腹膜癌：对犹太人群的影响。
Fam Cancer. 2004;3(3-4):265-81. doi: 10.1007/s10689-004-9554-y.
3
Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation.输卵管卵巢切除术与携带BRCA1或BRCA2基因突变女性患卵巢癌、输卵管癌和腹膜癌的风险
JAMA. 2006 Jul 12;296(2):185-92. doi: 10.1001/jama.296.2.185.
4
Clinical management of patients at inherited risk for gynecologic cancer.具有遗传性妇科癌症风险患者的临床管理
Curr Opin Obstet Gynecol. 2015 Feb;27(1):14-22. doi: 10.1097/GCO.0000000000000143.
5
The new FIGO staging system for ovarian, fallopian tube, and primary peritoneal cancer.国际妇产科联盟（FIGO）关于卵巢癌、输卵管癌和原发性腹膜癌的新分期系统。
Arch Gynecol Obstet. 2014 Nov;290(5):839-42. doi: 10.1007/s00404-014-3364-8. Epub 2014 Aug 1.
6
Cancer of the ovary, fallopian tube, and peritoneum.卵巢、输卵管和腹膜癌。
Int J Gynaecol Obstet. 2018 Oct;143 Suppl 2:59-78. doi: 10.1002/ijgo.12614.
7
Serous ovarian, fallopian tube and primary peritoneal cancers: a common disease or separate entities - a systematic review.浆液性卵巢癌、输卵管癌和原发性腹膜癌：一种常见疾病还是独立的实体——一项系统综述
Gynecol Oncol. 2015 Mar;136(3):571-81. doi: 10.1016/j.ygyno.2015.01.534. Epub 2015 Jan 20.
8
New insights in the pathophysiology of ovarian cancer and implications for screening and prevention.卵巢癌病理生理学的新见解及其对筛查和预防的意义。
Am J Obstet Gynecol. 2015 Sep;213(3):262-7. doi: 10.1016/j.ajog.2015.03.044. Epub 2015 Mar 25.
9
[Clinical recommendations for diagnosing, treatment and monitoring of patients with ovarian cancer -- Croatian Oncology Society and Croatian Society for Gynecology and Obstetrics as Croatian Medical Association units and Croatian Society of Gynecological Oncology].卵巢癌患者诊断、治疗及监测的临床建议——克罗地亚肿瘤学会、作为克罗地亚医学协会下属单位的克罗地亚妇产科协会以及克罗地亚妇科肿瘤学会
Lijec Vjesn. 2013 Sep-Nov;135(9-10):235-41.
引用本文的文献
1
Deciphering resistance mechanisms and novel strategies to overcome drug resistance in ovarian cancer: a comprehensive review.解析卵巢癌耐药机制及克服耐药策略的研究进展：综述
Oncol Res. 2024 Apr 23;32(5):831-847. doi: 10.32604/or.2024.031006. eCollection 2024.
2
Reviewing the Prospective Pharmacological Potential of Isothiocyanates in Fight against Female-Specific Cancers.综述异硫氰酸酯在对抗女性特异性癌症方面的潜在药理前景。
Cancers (Basel). 2023 Apr 20;15(8):2390. doi: 10.3390/cancers15082390.
3
SOX17 and PAX8 constitute an actionable lineage-survival transcriptional complex in ovarian cancer.SOX17和PAX8在卵巢癌中构成了一个可作用的谱系存活转录复合体。
Oncogene. 2022 Mar;41(12):1767-1779. doi: 10.1038/s41388-022-02210-3. Epub 2022 Feb 5.
4
Comprehensive Analysis of Tumor Microenvironment Identified Prognostic Immune-Related Gene Signature in Ovarian Cancer.肿瘤微环境的综合分析确定了卵巢癌的预后免疫相关基因特征
Front Genet. 2021 Feb 10;12:616073. doi: 10.3389/fgene.2021.616073. eCollection 2021.
5
Nck1 promotes the progression of ovarian carcinoma by enhancing the PI3K/AKT/p70S6K signaling.Nck1 通过增强 PI3K/AKT/p70S6K 信号促进卵巢癌的进展。
Hum Cell. 2020 Jul;33(3):768-779. doi: 10.1007/s13577-020-00344-8. Epub 2020 Mar 12.
6
Hybrid sequencing-based personal full-length transcriptomic analysis implicates proteostatic stress in metastatic ovarian cancer.基于杂交测序的个体全长转录组分析提示蛋白质稳态应激与转移性卵巢癌相关。
Oncogene. 2019 Apr;38(16):3047-3060. doi: 10.1038/s41388-018-0644-y. Epub 2019 Jan 7.
7
An evolving story of the metastatic voyage of ovarian cancer cells: cellular and molecular orchestration of the adipose-rich metastatic microenvironment.卵巢癌细胞转移之旅的演变故事：富含脂肪的转移性微环境中的细胞和分子协调作用。
Oncogene. 2019 Apr;38(16):2885-2898. doi: 10.1038/s41388-018-0637-x. Epub 2018 Dec 19.
8
A cancer vaccine with dendritic cells differentiated with GM-CSF and IFNα and pulsed with a squaric acid treated cell lysate improves T cell priming and tumor growth control in a mouse model.一种癌症疫苗，其树突状细胞经GM-CSF和IFNα分化，并用方形酸处理的细胞裂解物脉冲处理，可改善小鼠模型中的T细胞启动和肿瘤生长控制。
Bioimpacts. 2018;8(3):211-221. doi: 10.15171/bi.2018.24. Epub 2018 Jun 10.
9
Expression and prognostic value of CLIC1 in epithelial ovarian cancer.CLIC1在上皮性卵巢癌中的表达及预后价值
Exp Ther Med. 2018 Jun;15(6):4943-4949. doi: 10.3892/etm.2018.6000. Epub 2018 Mar 28.
10
Overexpression of the cancer stem cell marker CD117 predicts poor prognosis in epithelial ovarian cancer patients: evidence from meta-analysis.癌症干细胞标志物CD117的过表达预示上皮性卵巢癌患者预后不良：来自荟萃分析的证据。
Onco Targets Ther. 2017 Jun 13;10:2951-2961. doi: 10.2147/OTT.S136549. eCollection 2017.
本文引用的文献
1
A randomized phase II study of cabozantinib versus weekly paclitaxel in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study.卡博替尼对比每周紫杉醇治疗持续性或复发性上皮性卵巢癌、输卵管癌或原发性腹膜癌的随机 II 期研究：一项 NRG 肿瘤学/妇科肿瘤学组研究。
Gynecol Oncol. 2019 Mar;152(3):548-553. doi: 10.1016/j.ygyno.2018.12.008. Epub 2018 Dec 23.
2
Patterns of Recurrence and Clinical Outcome of Patients With Stage IIIC to Stage IV Epithelial Ovarian Cancer in Complete Response After Primary Debulking Surgery Plus Chemotherapy or Neoadjuvant Chemotherapy Followed by Interval Debulking Surgery: An Italian Multicenter Retrospective Study.IIIC期至IV期上皮性卵巢癌患者在初次肿瘤细胞减灭术加化疗或新辅助化疗后行中间型肿瘤细胞减灭术达到完全缓解后的复发模式及临床结局：一项意大利多中心回顾性研究
Int J Gynecol Cancer. 2017 Jan;27(1):28-36. doi: 10.1097/IGC.0000000000000843.
3
Genomics of Ovarian Cancer Progression Reveals Diverse Metastatic Trajectories Including Intraepithelial Metastasis to the Fallopian Tube.卵巢癌进展的基因组学揭示了多种转移途径，包括向输卵管的上皮内转移。
Cancer Discov. 2016 Dec;6(12):1342-1351. doi: 10.1158/2159-8290.CD-16-0607. Epub 2016 Oct 7.
4
AXL modulates extracellular matrix protein expression and is essential for invasion and metastasis in endometrial cancer.AXL调节细胞外基质蛋白的表达，对子宫内膜癌的侵袭和转移至关重要。
Oncotarget. 2016 Nov 22;7(47):77291-77305. doi: 10.18632/oncotarget.12637.
5
Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer.尼拉帕利维持治疗铂敏感复发性卵巢癌。
N Engl J Med. 2016 Dec 1;375(22):2154-2164. doi: 10.1056/NEJMoa1611310. Epub 2016 Oct 7.
6
Overall survival in patients with platinum-sensitive recurrent serous ovarian cancer receiving olaparib maintenance monotherapy: an updated analysis from a randomised, placebo-controlled, double-blind, phase 2 trial.奥拉帕利单药维持治疗铂敏感复发性浆液性卵巢癌患者的总生存期：一项随机、安慰剂对照、双盲、2 期临床试验的更新分析。
Lancet Oncol. 2016 Nov;17(11):1579-1589. doi: 10.1016/S1470-2045(16)30376-X. Epub 2016 Sep 9.
7
Establishment of Patient-Derived Tumor Xenograft Models of Epithelial Ovarian Cancer for Preclinical Evaluation of Novel Therapeutics.建立用于新型疗法临床前评估的上皮性卵巢癌患者来源的肿瘤异种移植模型。
Clin Cancer Res. 2017 Mar 1;23(5):1263-1273. doi: 10.1158/1078-0432.CCR-16-1237. Epub 2016 Aug 29.
8
Final results of a phase 3 study of trebananib plus weekly paclitaxel in recurrent ovarian cancer (TRINOVA-1): Long-term survival, impact of ascites, and progression-free survival-2.曲贝替定联合每周一次紫杉醇治疗复发性卵巢癌的3期研究（TRINOVA-1）的最终结果：长期生存、腹水影响及无进展生存期-2
Gynecol Oncol. 2016 Oct;143(1):27-34. doi: 10.1016/j.ygyno.2016.07.112. Epub 2016 Aug 18.
9
CRISPR/Cas9-Mediated Trp53 and Brca2 Knockout to Generate Improved Murine Models of Ovarian High-Grade Serous Carcinoma.CRISPR/Cas9介导的Trp53和Brca2基因敲除以生成改良的卵巢高级别浆液性癌小鼠模型。
Cancer Res. 2016 Oct 15;76(20):6118-6129. doi: 10.1158/0008-5472.CAN-16-1272. Epub 2016 Aug 16.
10
Genomic/Epigenomic Alterations in Ovarian Carcinoma: Translational Insight into Clinical Practice.卵巢癌的基因组/表观基因组改变：对临床实践的转化性见解
J Cancer. 2016 Jul 5;7(11):1441-51. doi: 10.7150/jca.15556. eCollection 2016.
Zotero 插件